Orchard’s ‘bubble baby’ therapy awarded PIM status

23rd August 2017 Uncategorised 0

UK regulators have awarded Orchard Therapeutics’ experimental ‘bubble baby’ disease therapy OTL-101 Promising Innovative Medicine status, pushing the drug closer to being accepted onto the Early Access to Medicines Scheme.

More: Orchard’s ‘bubble baby’ therapy awarded PIM status
Source: News